Regulus Therapeutics Inc
Change company Symbol lookup
Select an option...
RGLS Regulus Therapeutics Inc
RFTTQ RAIT FINANCIAL 7.625% SNR NTS
TACT TransAct Technologies Inc
TXN Texas Instruments Inc
T AT&T Inc
SXT Sensient Technologies Corp
SUPN Supernus Pharmaceuticals Inc
SIMO Silicon Motion Technology Corp
RFIL RF Industries Ltd
REED Reed's Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap BlendCompany profile

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a range of diseases. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs to modulate microRNAs and return diseased cells to their healthy state. The Company's Regulus microMarkers division is focused on identifying microRNAs as biomarkers of human disease. It has a research collaboration with Biogen focused on the discovery of microRNAs as biomarkers for multiple sclerosis and has completed research for another pharmaceutical company to explore microRNAs as biomarkers for specific patient populations. The Company is developing RG-101, an N-Acetylgalactosamine (GalNAc)-conjugated anti-miR targeting miR-122; RG-012, an anti-miR targeting microRNA-21 for the treatment of Alport syndrome, and RG-125, a GalNAc-conjugated anti-miR targeting microRNA-103/107.

Closing Price
$0.7799
Day's Change
0.0235 (3.11%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.78
Day's Low
0.7348
Volume
(Light)
Volume:
27,001

10-day average volume:
125,991
27,001
  • Prev Close
    0.7564
  • Today's Open
    0.7577
  • Day's Range
    0.7348-0.78
  • Avg Vol (10-day)
    126.0K
  • Last (time)
    3:59p ET 12/06/19
  • Last (size)
    1.2K
  • 52-Wk Range
    0.5026 - 1.65
    LowHigh
  • (12/07/18 - 08/06/19)
    55.17%
  • 102.3%
  • Market Cap
    16.3M
  • Shares Outstanding
    20.9M
  • -1.85
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.5
  • 42.74
  • (% of float 11/15/19)
    1.55

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.